ZNF558 Inhibitors
Chemical inhibitors of ZNF558 can regulate the activity of this protein through various molecular pathways by targeting the enzymes that modulate the transcription factors controlling ZNF558. Chelerythrine and Go6976, both inhibitors of protein kinase C (PKC), can reduce the phosphorylation of transcription factors that are necessary for ZNF558 function. The impact is a decrease in the functional activity of ZNF558 due to less active transcription factors. Similarly, GF109203X and Bisindolylmaleimide I also target PKC, leading to diminished phosphorylation and activity of transcription factors regulating ZNF558, which in turn inhibits the protein's functionality.
Further inhibition of ZNF558 is accomplished through the blocking of other key kinases in signaling pathways. PD98059 and U0126 are inhibitors of MEK, which is upstream of extracellular signal-regulated kinases (ERKs); these are essential for the activation of transcription factors that regulate ZNF558. By inhibiting MEK, these chemicals can reduce the activation of ERK and downstream transcription factors, thereby inhibiting ZNF558. Additionally, LY294002 and Wortmannin, both PI3K inhibitors, impede the PI3K signaling pathway, crucial for transcription factor activity, leading to reduced functionality of ZNF558. SP600125 and SB203580 target the JNK and p38 MAP kinase pathways, respectively, and by inhibiting these kinases, they can decrease the activity of transcription factors pivotal for ZNF558 function. Lastly, Y-27632, which inhibits Rho-associated protein kinase (ROCK), can indirectly diminish ZNF558 activity by altering the dynamics of transcription factor localization and function, which is crucial for the proper regulation of ZNF558.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine inhibits protein kinase C (PKC), which affects various transcription factors. ZNF558 function could be regulated by transcription factors influenced by PKC, hence inhibition of PKC could lead to a decrease in ZNF558 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits mitogen-activated protein kinase kinase (MEK), which is upstream of extracellular signal-regulated kinases (ERKs) that can regulate transcription factor activity. These transcription factors may control ZNF558 activity, so PD98059 could reduce ZNF558 activity by inhibiting MEK and subsequent ERK activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor that can impede signaling required for transcription factor activation. Since these transcription factors could govern ZNF558 function, LY294002's inhibition of PI3K could diminish ZNF558 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), affecting transcription factors that modulate ZNF558 function. Inhibition of JNK by SP600125 could thus decrease ZNF558 activity by reducing transcription factor activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which regulates transcription factors. Transcription factors influenced by p38 MAP kinase could control ZNF558 activity; thus, SB203580 could reduce ZNF558 activity by inhibiting p38 MAP kinase. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, blocking downstream signals essential for transcription factor activity that may control ZNF558 function. Wortmannin's inhibition of PI3K could, therefore, inhibit ZNF558 activity. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 inhibits classical PKC isoforms and could disrupt phosphorylation and activation of transcription factors regulating ZNF558, potentially inhibiting ZNF558 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinase (ROCK), which can affect transcription factor localization and function, thereby potentially inhibiting ZNF558 activity by altering transcription factor dynamics. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK in the ERK pathway, reducing activation of transcription factors that could be crucial for ZNF558 activity. Thus, U0126 could indirectly inhibit ZNF558 function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a PKC inhibitor that can reduce transcription factor phosphorylation necessary for ZNF558 function, leading to inhibition of ZNF558. | ||||||